Lynas is overvalued, not undervalued. Can you tell me what ruler you are using? You give nothing to judge your statement with except your own fantasies. I use the oldest ruler around and still the standard. It is comparing Market Cap to Earnings, Revenue, and Book value. Two things will make these look even worse in the next 3 months. 2023 SAR which will be way below 2022 AR - 2022 SAR or 1/2 2022 AR. . A Deeping recession which drops the multiple of all Stocks not just Lynas. Lynas has been over valued for years which you still do not seem to understand, The fact that ASX 200 is only down 7.5% while Lynas is down 29.5% YTD says many more people agree with me than disagree.
I can show why I think Lynas will see six before it sees 9 again. What do you think it is worth.
I am pretty sure your prediction of 22 AUD in 2022 will not happen. also saying the 4 % drop below 9.00 did not bother you. that was the drop that started this fall to 7.78 and probably further.
- Forums
- ASX - By Stock
- LYC
- Lynas - Never fails to disappoint
LYC
lynas rare earths limited
Add to My Watchlist
3.48%
!
$8.88

Lynas - Never fails to disappoint, page-445
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$8.88 |
Change
-0.320(3.48%) |
Mkt cap ! $8.306B |
Open | High | Low | Value | Volume |
$9.44 | $9.44 | $8.86 | $61.13M | 6.800M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 225 | $8.88 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.91 | 24100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2 | 8.880 |
1 | 80 | 8.850 |
1 | 508 | 8.830 |
1 | 675 | 8.820 |
6 | 3145 | 8.800 |
Price($) | Vol. | No. |
---|---|---|
8.930 | 200 | 1 |
8.950 | 200 | 1 |
8.960 | 650 | 1 |
8.990 | 164 | 1 |
9.020 | 1100 | 1 |
Last trade - 16.11pm 27/06/2025 (20 minute delay) ? |
Featured News
LYC (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online